Report Library
All Reports
How Pharma Copes with the Pain of Developing Abuse-Deterrent Opioids
January 16, 2015
With the wide availability of generic opioid analgesics, such as oxycodone and hydromorphone, the abuse of prescription opioids has
become a major public health problem in the US. Citeline analyst, Heidi Chen, PhD, examines how pharma copes with the pain of
developing abuse-deterrent opiods.
For more information about Citeline, or to view their other white paper reports, please visit Citeline here.
For the full report, please download the PDF version at the top of this page.
Disease Group Covered: | Neurology |
Indications Covered: |
Guillain-Barré Syndrome
Ischemic Stroke Post-Traumatic Stress Disorder (PTSD) Premenstrual Dysphoric Disorder (PMDD) Sleep Apnea Smoking Cessation Substance Use Disorder |